Ask AI
ProCE Banner Activity

Q&A on Infant RSV Prevention: Putting Experts in the Hot Seat

Clinical Thought

Read answers to learner questions from a symposium on how to tailor infant RSV prevention strategies to the needs of individual infants and caregivers, including specific questions on timing of immunizations and determining patient eligibility.

Released: May 18, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

 

Merck & Co., Inc., Rahway, NJ, USA

Target Audience

This activity is intended for pediatricians and other healthcare professionals involved in RSV prevention in infants.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Assess the overall burden of infant RSV infections on children, parents and caregivers, and the health system

Disclosure

Primary Author

Pablo J. Sanchez, MD: consultant/advisor/speaker: Blue Lake Biotechnology/CyanVac, Kamada, Merck Sharp & Dohme.

Michael J. Smith, MD, MSCE: researcher: Merck, Pfizer.

Brenda L. Tesini, MD: other financial or material support: Merck.